Last Updated : April 26, 2011
Details
FilesGeneric Name:
Eltrombopag olamine
Project Status:
Complete
Therapeutic Area:
Chronic immune thrombocytopenic purpura
Manufacturer:
GlaxoSmithKline
Call for patient/clinician input open:
Brand Name:
Revolade
Project Line:
Reimbursement Review
Project Number:
SR0230-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Thrombocytopenic purpura chronic immune (idiopathic)
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : April 26, 2011